Inflammation and the expression of dopamine and 5-HT receptors in colonic mucosa of Parkinson's rats

doi:10.3969/j.issn.1006-7795.2018.05.012

Abstract

Abstract: Objective To report the distribution of dopamine (DA) and serotonin (5-HT) receptors in the colonic muscular layer and their potential role in the motility regulation in the Parkinson's disease (PD) model 6-hydroxydopamine (6-OHDA) rats, it is not clear their expressions in the colonic mucosa and correlation with the colonic mucosal dysfunction in the PD rats. The present study aims to investigate the distribution of DA and 5-HT receptors in the colonic mucosa, and the colonic mucosal inflammatory and permeability and the expression change of the DA and 5-HT receptors in the colonic mucosa in 6-OHDA rats. Methods Injection of 6-OHDA to the bilateral substantia nigras of rats, to make PD model (6-OHDA rats). Immunofluorescence (IF) and western blotting were used to observe the injection sites and the extent of DA neurons' injury. DA and 5-HT content was measured by high performance liquid chromatography-electrochemistry detection (HPLC-EDC). The mRNA and protein expression of DA receptors (D₁, D₂, D₅) and 5-HT receptors (5-HT₃, 5-HT₄) was detected by Real-time PCR and Western blotting. Results In the 6-OHDA rats, the protein expression of tyrosine hydroxylase (the synthetic rate-limiting enzyme of dopamine) in substantia nigra was decreased (control:0.335±0.073, model:0.132±0.028, P<0.05), fecal water content was reduced[control:(0.119±0.005)%, model:(0.062±0.006)%, P<0.01] and the time of rotarod test was shortened[control:(35.330±3.148)s, model:(24.000±1.424)s, P<0.01], indicating the model is successful. Furthermore, the colonic transepithelial resistance was decreased[control:(73.750±4.024)Ω/cm², model:(53.400±6.282)Ω/cm², P<0.05], the mucosal fluorescein isothiocyanate (FITC)-dextran permeability was increased[at 60 minutes, control:(18.860±1.856)μg/L, model:(37.000±4.457)μg/L, P<0.01], and the TNF-α was also increased[control:(269.10±18.00)ng/g, model:(340.40±21.52)ng/g, P<0.05], suggesting a higher mucosal permeability and inflammation. In the colonic mucosa of 6-OHDA rats, the expression of D₁[control:(0.728±0.132), model:(0.272±0.067), P<0.01] and D₅ (control:0.721±0.036, model:0.543±0.051, P<0.05) were decreased, but the DA and 5-HT content, and the receptors D₂, 5-HT₃ and 5-HT₄ had no significant alteration although 5-HT₃ (control:0.078±0.016, model:0.103±0.034, P>0.05) had a increase tendency. Conclusion The present study demonstrates that 6-OHDA rats manifest a reduction of D₁ and D₅ expressions in colonic mucosa, and increase in colonic mucosal permeability and TNF-α level, which suggests a colonic mucosal inflammation. However, whether the reduction of colonic D₁ and D₅ is involved in the formation of mucosal inflammation in 6-OHDA rats needs to be further investigated.

Key words: dopamine, serotonin, mucosal permeability, inflammation

CLC Number:

R574.62

Zhang Yue, Li Yun, Zhang Xiaoli, Feng Xiaoyan, Quan Zhusheng, Zhu Jinxia. Inflammation and the expression of dopamine and 5-HT receptors in colonic mucosa of Parkinson's rats[J]. Journal of Capital Medical University, 2018, 39(5): 685-692.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/10.3969/j.issn.1006-7795.2018.05.012

https://journal03.magtech.org.cn/Jweb_sdykdxxb/EN/Y2018/V39/I5/685

References

[1] Shao W, Zhang S Z, Tang M, et al. Suppression of neuroinflammation by astrocytic dopamine D2 receptors via alpha B-crystallin[J].Nature, 2013, 494(7435):90-94.
[2] Yan Y, Jiang W, Liu L, et al. Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome[J].Cell, 2015, 160(1-2):62-73.
[3] Yang N, Tian Y M, Zhang X H, et al. A dual role of 5-hydroxytryptamine receptor 3 in serotonin induced ion transport in rat distal colon[J].Eur J Pharmacol, 2008, 584(1):137-143.
[4] Spohn S N, Bianco F, Scott R B, et al:Protective actions of epithelial 5-hydroxytryptamine 4 receptors in normal and inflamed colon[J]. Gastroenterology, 2016, 151(5):933-944.
[5] Singh P, Dutta S R, Guha D. Gastric mucosal protection by aegle marmelos against gastric mucosal damage:role of enterochromaffin cell and serotonin[J].Saudi J Gastroenterol, 2015, 21(1):35-42.
[6] Manzella C, Singhal M, Alrefai W A, et al. Serotonin is an endogenous regulator of intestinal CYP1A1 via AhR[J].Sci Rep, 2018, 8(1):6103.
[7] Politis M, Niccolini F. Serotonin in parkinson's disease[J].Behav Brain Res, 2015, 277:136-145.
[8] George S A, Knox D, Curtis A L, et al. Altered locus coeruleus-norepinephrine function following single prolonged stress[J].Eur J Neurosci, 2013, 37(6):901-909.
[9] Zhang X, Li Y, Liu C, et al. Alteration of enteric monoamines with monoamine receptors and colonic dysmotility in 6-hydroxydopamine-induced Parkinson's disease rats[J].Transl Res, 2015, 166(2):152-162.
[10] Song J, Zheng L, Zhang X, et al. Upregulation of beta1-adrenoceptors is involved in the formation of gastric dysmotility in the 6-hydroxydopamine rat model of Parkinson's disease[J].Transl Res, 2014, 164(1):22-31.
[11] Zheng L F, Song J, Fan R F, et al. The role of the vagal pathway and gastric dopamine in the gastroparesis of rats after a 6-hydroxydopamine microinjection in the substantia nigra[J].Acta Physiol (Oxf), 2014, 211(2):434-446.
[12] Zhang G H, Zhu J X, Xue H, et al. Dopamine stimulates Cl^- absorption coupled with HCO₃^- secretion in rat late distal colon[J].Eur J Pharmacol, 2007, 570(1-3):188-195.
[13] Feng X Y, Zhang D N, Wang Y A, et al. Dopamine enhances duodenal epithelial permeability via the dopamine D5 receptor in rodent[J].Acta Physiol, 2017, 220(1):113-123.
[14] Magro F, Vieira-Coelho M A, Fraga S, et al. Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease[J].Dig Dis Sci, 2002, 47(1):216-224.
[15] Devos D, Lebouvier T, Lardeux B, et al. Colonic inflammation in Parkinson's disease[J].Neurobiol Dis, 2013, 50:42-48.
[16] Pellegrini C, Fornai M, Colucci R, et al. Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration[J].J Neuroinflammation, 2016, 13(1):146.
[17] 孙路, 冯小燕,郑丽飞,等.多巴胺受体在人与小鼠胃黏膜泌生长抑素细胞中的分布[J].首都医科大学学报,2015,36(3):432-436.
[18] 张悦, 李蕴,朱进霞,等.多巴胺受体在大鼠结肠黏膜下神经丛的表达和细胞分布[J]. 首都医科大学学报,2017,38(3):411-416.